LIAISON XL MUREX HBsAg Quant - Hepatitis B virus surface antigen IVD, kit, chemiluminescent immunoassay

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
22-11-2017

Boleh didapati daripada:

DiaSorin Australia Pty Ltd

Kelas:

Class 4

Dikeluarkan oleh:

DiaSorin Italia SpA Via Crescentino snc, Saluggia VC, 13040 Italy

Kawasan terapeutik:

48321 - Hepatitis B virus surface antigen IVD, kit, chemiluminescent immunoassay

Tanda-tanda terapeutik:

LIAISON? XL MUREX HBsAg Quant assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of hepatitis B surface antigen (HBsAg) in human serum or plasma samples. For the quantitative determination of Hepatitis B surface Antigen (HBsAg) in human serum and plasma samples, including specimens collected up to 24 hours post-mortem (non-heart beating).

Status kebenaran:

A

Tarikh kebenaran:

2013-07-20

Cari amaran yang berkaitan dengan produk ini